| 产品名称: | Human astrovirus |
|---|---|
| 商品货号: | TS213812 |
| Classification: | Astroviridae, Mamastrovirus, Mamastrovirus 1 |
| Agent: | Human astrovirus |
| Strain: | Type 1 |
| Applications: | Virucide testing In vitro infectivity assay Antiviral Studies Spiking studies ELISpot Assay Virus neutralization assay Virus ultrastructural studies Immunological-based assays PCR-based assay validation Research and development Assay development Vaccine development |
| Biosafety Level: | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format: | frozen 1.0 mL per vial |
| Storage Conditions: | -70°C or colder |
| Images: | |
| Comments: | Freeze-thaw twice at harvest. |
| Effect on Host: | No visible CPE – confirm infection by IFA. Sloughing and detachment may result from trypsin supplemented growth medium. |
| Recommended Host: | CaCo-2 cells (ATCC® HTB-37™) |
| Growth Conditions: | Temperature: 37°C Recommendations for Infection: Plate cells 18-24 hours prior to infection and infect when cultures are 90-100% confluent. Pre-treat inoculum in EMEM (ATCC® 30-2003™) + 5 µg/mL 1X-S trypsin (Sigma-Aldrich® T0303) for 30 minutes at 37°C. Remove medium from host cells and rinse twice with 1X DPBS. Inoculate with a small volume of virus (e.g. 1 mL per 25 cm2) diluted to provide an optimal MOI (e.g. 1.0). Adsorb 1 hour at 37°C in a humidified 5% CO2 atmosphere. End adsorption by removing inoculum and adding virus growth medium. Incubation: 1-5 days at 37°C in a humidified 5% CO2 atmosphere, until CPE is progressed through 80% of the monolayer. |
| Name of Depositor: | J Vinje, CDC, Division of Viral Diseases |
| Source: | Human stool sample, Oxford, UK |
| References: | Lee TW, Kurtz JB. Prevalence of human astrovirus serotypes in the Oxford region 1976-92, with evidence for two new serotypes. Epidemiol Infect. 1112(1): 187-193, 1994. PubMed: 8119358 |